Director Declaration

Bridgepoint Group plc
01 July 2024
 

Bridgepoint Group plc
 ("Bridgepoint" or the "Company")

 

Director Declaration


In accordance with Listing Rule 9.6.14R, the Company advises that Cyrus Taraporevala, an Independent Non-Executive Director, has been appointed as a Non-Executive Director of Pfizer Inc.


ENQUIRIES:

 

Bridgepoint

 

Analysts and investors

Adam Key

adam.key@bridgepoint.eu

+44 7833 748010

 

Media

Christian Jones / James Murray

christian.jones@bridgepoint.eu james.murray@bridgepoint.eu

+44 20 7034 3500

 

FGS Global (Public Relations Adviser to Bridgepoint)

 

Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656

 

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

 

bridgepoint@fgsglobal.com 

 

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Bridgepoint Group (Reg S) (BPT)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today